CCI: Bid-submission by ineligible pharma-dealer, not dominance abuse; Rejects complaint given no competition concerns
Jan 12, 2022
|
Simply Register/Sign In to access the free content across the portals!
Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals